After CBC News asked the department about the websites advertising BPC-157, it said it was investigating whether those activities complied with the Food and Drugs Act
Full disclaimer 1.AOD-9604 is a 16-amino acid peptide fragment derived from human growth hormone (hGH residues 177-191) with added tyrosine, developed by Metabolic Pharmaceuticals for obesity treatment 2.Proposed mechanism: selective stimulation of lipolysis (fat breakdown) and inhibition of lipogenesis (fat formation) without growth hormone-like effects on IGF-1 or blood glucose 3.Failed Phase 2b clinical trial for obesity (2007)did not demonstrate statistically significant weight loss versus placebo, terminating clinical development for this indication 4.Received FDA "Generally Recognized as Safe" (GRAS) designation in 2023 as a food substance, but this is NOT a drug approval and does not establish efficacy for weight loss 5.Regulatory status: not FDA-approved as a drug, prohibited by WADA, and insufficient evidence for weight loss efficacy
They are used as supportive therapy following clinical assessment
Great customer service and quality treatment Lauren is AMAZING
Brecht Rudi en Nicole Van Renterghem Pattyn says: Dirk, We wensen u een goede reis toe
Helps improve quality of life by reducing nausea-related discomfort Can be used safely in pregnant women for morning sickness under medical supervision Amino Blend Muscle recovery, Athletic endurance, Tissue repair $40 Read Benefits Amino acids are building blocks for proteins, essential for bodily functions
